virtually all of the fungi are yeast and in the sinus, most are molds. So I don't want to overextend the concept, but I simply want to say that there is no proven cause-andeffect relationship between ototopical quinolones and the increasing incidence of fungal infections in the ear.
Dr. Poole: I would say that a different way : Since no antibacterial treats or eradicates fungi, all must be capable in some settings of changing the balance of the skin or mucosal flora more towar d yeast overgrowth, particularly if the preparatio n has no funga l inhibitory effect. Since an acidic environment inhibits overgrow th of all types of "normal flora," there is every reason to susp ect that a neutral quinol one preparation (such as ofloxac in otic) may increase the rate of yeast problems. I believe, along with many of our colleagues, that this has been the case in the past few years.
Perioperative prophylax is

Do drops make a difference?
Dr. Doh ar: Drops are ofte n used at the time oftube placement as prophylaxis. Do you think this is appropria te?
Dr. Pool e: By my reading of the various trials, drops do make a difference, but only in certain patients. By and large, drops are helpful if the patient has a mucoid or purulent effusion at the time of tube insertion. In general, there is no measurable benefit in patients with dry ears or serous effusions. So although we call intraoperative use "prophylactic," in reality it makes a real therapeutic difference for those ears that we know are infected and for those ears that might be infecte d. Therefore, we are really therapeutically treating infected ears, and we should use the drops in patients who are at risk of being infecte d at the time of tube insertion .
Steroid vs. no steroid
Dr. Doh ar: Once we decide to use a broad-spectrum ototopical perioperat ively, ournext decision is to choose between ciprofloxacinldexamethasone and ofloxacin. Keeping in mind that neither of these drops has been approved for perioperative prophylaxis at the time of tympanostomy tube insertio n and that we have no head-to-head data to compare them, is there reason to think that one is more effective than the other? Dr. Poole: For the treatment of ears that are infected, we have every reason to believe that the addition of a stero id will result in a better outcome because you treat both infection and inflammation . So I prefer ciprofloxacinl dexamethasone. For ears that are not infected, the cho ice of a prophylactic is a toss-up.
Dr. Antonelli:
Many data indicate that there is value in using a steroid in the middle ear to treat otitis. The most recent studies on the combination of ciprofloxacin and dexamethasone are the most compe lling, but much older studies have shown this with the combinatio n of'aminoglycosides and dexamethasone as well.The topical antibiotics can kill the bacteria, but they don't do anything for the host inflammatory response and the collateral tissue damage that it can perpetuate. On the basis of the available data, the theoret ical benefits, and my personal experience, there is no quest ion that the combination product is the better choice .
Dr. Dohar:
At the University of Pittsburgh, it is a rare occasion when I place a tympanostomy tube into an acutely infected ear. By the time my patients are ready to receive a tube, their infection has already been treated. These patients most likely have OME rather than AOM . Studies have shown that approximately one-third of all ears with OME are culture-positive and two-thirds are sterile by traditional culture methods . We can assume that culture-negative patients have noninfectious inflammation . Therefore, in these two-thirds of patients, the decision is not whether to use an antibiotic/steroid combination or an antibiotic alone. The decision is whether to use an antibiotic/steroid combination or a steroid alone. We have no data, but I believe that a steroid alone would be sufficient. In these cases, the pathogens have been eradicated and we are merely treating resistant inflammation.
However, for the one-third of patie nts who are culture-positive, I agree in theory that the antibiotic/stero id combination makes more sense than the antibiotic alone because we don't know exactly which patients are culture-positive at the outset. So the logical choice is to use ciprofloxacinldexamethasone. Moreover, ifyou treat with an antibiotic alone, you're not providing optimal treatment for the inflammation.
The Daiichi studies showed that cure rates with ofloxacin are only about 80% .7 If approximately 20% of patients are not responding to ofloxacin in a controlled research environment, who knows how many are not responding in actual clinical practice? Meanwhile, as we said, cure rates with ciprofloxacinldexamethasone are much better. So even without head -to-head data, the argument for using ciprofloxacinldexamethasone is sound.
Dr. Poole: Is there any downside to using a steroid during tube placement?
Dr. Antonelli: A report from Sweden described a model for chronic nonhealing perforations that involved a myringotomy and the application ofa steroid." In a noninflamed ear, a steroid might cause some sort ofproblem. There are isolated reports ofnon healing perforations after intratympanic steroid injections for inner ear disorders without associated middle ear inflammation.'? I've never personally observed a persistent tympanic membrane perforation with the use of topical steroids and otitis-related perforations.
Complications should not be a problem in an inflamed ear because the healing response is heightened and the steroid concentration is not particularly high. In fact, when I administer steroid injections to patients with autoimmune inner ear disease, the steroid concentration that I use is much higher than the concentration in the ciprofloxacinl dexamethasone drop. And despite the high concentrations and the repeated exposures, it is very unusual to see a tympanic membrane perforation.
Dr. Dohar: So even though we have no clinical data to prove it, we agree that the risk-benefit ratio in choosing ciprofloxacinldexamethasone is clearly on the benefit side of the equation.
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The addition of a steroid to an antibiotic in an infected ear will increase the chances of a good outcome because the steroid treats the inflammation and allows the antibiotic to reach the source of infection.-Dr. Poole Dr. Poole: I have some concern about using an antibiotic/ steroid combination at the time oftube insertion in a child who has a normal or almost-normal tympanic membrane. In fact, as I alluded earlier, I doubt we should put anything into those ears. But I suspect that most otologic surgeons do administer perioperative prophylaxis to most ears.
Certainly, we don't need to use drops in a dry ear. But when a physician has an infectious reason to use drops at the time of surgery, ciprofloxacinldexamethasone, as the only ototopical with the potent steroid, is preferred.Perhaps not every physician will agree with this, but the addition ofthe steroid will increase the chances ofa good outcome because, again, it treats the inflammation and allows the antibiotic to reach the source of infection.
Dr. Dohar: Many pediatricians use a steroid only when the child has pain, and therefore they don't see a need for ciprofloxacinldexamethasone for AOMT. They perceive it as a bigger gun than ofloxacin. But the antibiotic component of the two ototopicals is similar. If they're not using ciprofloxacinldexamethasone because the child has no pain, they're completely overlooking the potential for inflammat ion in the middle ear to increase morbidity.
Cost
Dr. Dohar: As you know, when making a cost analysis, there are factors to consider beyond the price of a single prescription. Ifyou conduct a sophisticated pharmacoeconomic analysis of two drugs, you may find, for example, that the less-expensive drug is associated with a 14% failure rate , while the more-expensive agent has a failure rate of only 4%.
Dr. Antonelli: We also should look at the costs involved in starting with amoxicillin and then switching to an ototopical and possibly a broader-spectrum oral agent later if amoxicillin fails. Moreover, we can't ignore the costs involved in time lost from work by parents who stay home with a child with a draining ear. There's a lot more to it than just the cost of the initial drug.
.
